Evaluación de Tecnologías Sanitarias

Short-term exposure to particulate matter (PM(10) and PM(2.5)), nitrogen dioxide (NO(2)), and ozone (O(3)) and all-cause and cause-specific mortality: Systematic review and meta-analysis

P. Orellano,J. Reynoso,N. Quaranta,A. Bardach and A. Ciapponi. Short-term exposure to particulate matter (PM(10) and PM(2.5)), nitrogen dioxide (NO(2)), and ozone (O(3)) and all-cause and cause-specific mortality: Systematic review and meta-analysis. Environ Int. 2020;142:10.1016/j.envint.2020.105876.

Short-term exposure to particulate matter (PM(10) and PM(2.5)), nitrogen dioxide (NO(2)), and ozone (O(3)) and all-cause and cause-specific mortality: Systematic review and meta-analysis Ver más »

Seroprevalence and lethality by SARS-CoV-2 in indigenous populations of Latin America and the Caribbean: a systematic review

A. Hernández-Vásquez,F. Chavez-Ecos,A. Barrenechea-Pulache,D. Comandé and G. Bendezu-Quispe. Seroprevalence and lethality by SARS-CoV-2 in indigenous populations of Latin America and the Caribbean: a systematic review. PeerJ. 2021;9:10.7717/peerj.12552.

Seroprevalence and lethality by SARS-CoV-2 in indigenous populations of Latin America and the Caribbean: a systematic review Ver más »

Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis (Review)

A. Ciapponi,A. Bardach,L. R. Ares,D. Glujovsky,M. L. Cafferata,S. Cesaroni and A. Bhatti. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis (Review). Cochrane Database of Systematic Reviews. 2019(12):10.1002/14551858.CD011250.pub2.

Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis (Review) Ver más »

SELF-REPORTED POPULATION HEALTH BASED ON EUROQOL EQ-5D: POPULATION NORMS FROM ARGENTINA, BRAZIL, CHILE AND URUGUAY

L. Rey-Ares,P. Kind,G. Fernandez,M. V. Andrade,V. Zarate,A. Perna,K. Noronha and F. Augustovski. SELF-REPORTED POPULATION HEALTH BASED ON EUROQOL EQ-5D: POPULATION NORMS FROM ARGENTINA, BRAZIL, CHILE AND URUGUAY. Value in Health. 2016;19(3):10.1016/j.jval.2016.03.1933.

SELF-REPORTED POPULATION HEALTH BASED ON EUROQOL EQ-5D: POPULATION NORMS FROM ARGENTINA, BRAZIL, CHILE AND URUGUAY Ver más »

Second-Line Therapy In Children With Asthma In Colombia: An Economic Evaluation To Inform The National Guideline

F. Augustovski,S. G. Marti,M. Glanszpiegel,G. Perman,N. Albaytero,C. M. Rodriguez and A. Souto. SECOND-LINE THERAPY IN CHILDREN WITH ASTHMA IN COLOMBIA: AN ECONOMIC EVALUATION TO INFORM THE NATIONAL GUIDELINE. Value in Health. 2013;16(3):10.1016/j.jval.2013.03.1200.

Second-Line Therapy In Children With Asthma In Colombia: An Economic Evaluation To Inform The National Guideline Ver más »

Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid review

A. Ciapponi,A. Bardach,A. Mazzoni,T. Alconada,S. Anderson,F. J. Argento,J. Ballivian,K. Bok,D. Comandé,E. Erbelding,E. Goucher,B. Kampmann,R. Karron,F. M. Munoz,M. C. Palermo,E. P. K. Parker,F. Rodriguez Cairoli,M. V. Santa,A. Stergachis,G. Voss,X. Xiong,N. Zamora,S. Zaraa,M. Berrueta and P. M. Buekens. Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid review. medRxiv. 2021:10.1101/2021.06.03.21258283.

Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid review Ver más »

Rotavirus Vaccine Impact since Its Introduction in the National Immunization Program of Argentina

S. G. Marti,L. Gibbons,S. Reidel,J. Stupka,J. Degiuseppe,F. Argento and J. A. Gómez. Rotavirus Vaccine Impact since Its Introduction in the National Immunization Program of Argentina. Infect Dis Ther. 2022:10.1007/s40121-022-00709-6.

Rotavirus Vaccine Impact since Its Introduction in the National Immunization Program of Argentina Ver más »

Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration

D. Husereau,M. Drummond,S. Petrou,D. Greenberg,J. Mauskopf,F. Augustovski,A. H. Briggs,D. Moher,E. Loder and C. Carswell. Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration. Pharmacoeconomics. 2015;33(5):10.1007/s40273-015-0277-8.

Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration Ver más »

Remote non‐pharmacologic interventions for sleep problems in healthcare workers during the COVID‐19 pandemic

F. M. Torrente,P. L. López,D. Comandé,D. Ailan,S. E. Fernandez Nievas,L. Robertson and A. Ciapponi. Remote non‐pharmacologic interventions for sleep problems in healthcare workers during the COVID‐19 pandemic. Cochrane Database of Systematic Reviews. 2021(5):10.1002/14651858.CD015132.

Remote non‐pharmacologic interventions for sleep problems in healthcare workers during the COVID‐19 pandemic Ver más »